Evolutionary and Functional Data Power Search for Obsessive-Compulsive Disorder Genes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Identification of the Transforming STRN-ALK Fusion As a Potential Therapeutic Target in the Aggressive Forms of Thyroid Cancer
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer Lindsey M. Kellya,1, Guillermo Barilab,1, Pengyuan Liuc,1, Viktoria N. Evdokimovaa, Sumita Trivedid, Federica Panebiancoa, Manoj Gandhia, Sally E. Cartye, Steven P. Hodakf, Jianhua Luoa, Sanja Dacica, Yan P. Yua, Marina N. Nikiforovaa, Robert L. Ferrisd, Daniel L. Altschulerb, and Yuri E. Nikiforova,2 aDepartment of Pathology and Laboratory Medicine, bDepartment of Pharmacology and Chemical Biology, dDepartment of Otolaryngology, eDepartment of Surgery, Division of Endocrine Surgery, and fDepartment of Medicine, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and cDepartment of Physiology and Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226 Edited* by Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH, and approved January 10, 2014 (received for review November 24, 2013) Thyroid cancer is a common endocrine malignancy that encom- However, a significant proportion of thyroid cancers have no passes well-differentiated as well as dedifferentiated cancer types. known driver mutations. The discovery of novel genetic events The latter tumors have high mortality and lack effective therapies. has been accelerated more recently due to the availability of next- Using a paired-end RNA-sequencing approach, we report the dis- generation sequencing approaches that allow investigators to ob- covery of rearrangements involving the anaplastic lymphoma tain information on the entire genome, exome, or transcriptome kinase (ALK) gene in thyroid cancer. The most common of these of tumor cells (6). In this study, we used whole-transcriptome involves a fusion between ALK and the striatin (STRN) gene, which [RNA-sequencing (RNA-Seq)] analysis to identify novel gene fu- is the result of a complex rearrangement involving the short arm sions in thyroid cancer. -
Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Co-Regulator in Invasive 6 Lobular Carcinoma of the Breast 7 8 Evelyn K
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.16.423142; this version posted December 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Running Title: MDC1 co-regulates ER in ILC 2 3 Research article 4 5 Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive 6 lobular carcinoma of the breast 7 8 Evelyn K. Bordeaux1+, Joseph L. Sottnik1+, Sanjana Mehrotra1, Sarah E. Ferrara2, Andrew E. Goodspeed2,3, James 9 C. Costello2,3, Matthew J. Sikora1 10 11 +EKB and JLS contributed equally to this project. 12 13 Affiliations 14 1Dept. of Pathology, University of Colorado Anschutz Medical Campus 15 2Biostatistics and Bioinformatics Shared Resource, University of Colorado Comprehensive Cancer Center 16 3Dept. of Pharmacology, University of Colorado Anschutz Medical Campus 17 18 Corresponding author 19 Matthew J. Sikora, PhD.; Mail Stop 8104, Research Complex 1 South, Room 5117, 12801 E. 17th Ave.; Aurora, 20 CO 80045. Tel: (303)724-4301; Fax: (303)724-3712; email: [email protected]. Twitter: 21 @mjsikora 22 23 Authors' contributions 24 MJS conceived of the project. MJS, EKB, and JLS designed and performed experiments. JLS developed models 25 for the project. EKB, JLS, SM, and AEG contributed to data analysis and interpretation. SEF, AEG, and JCC 26 developed and performed informatics analyses. MJS wrote the draft manuscript; all authors read and revised the 27 manuscript and have read and approved of this version of the manuscript. -
The MAP4K4-STRIPAK Complex Promotes Growth and Tissue Invasion In
bioRxiv preprint doi: https://doi.org/10.1101/2021.05.07.442906; this version posted May 8, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 The MAP4K4-STRIPAK complex promotes growth and tissue invasion in 2 medulloblastoma 3 Jessica Migliavacca1, Buket Züllig1, Charles Capdeville1, Michael Grotzer2 and Martin Baumgartner1,* 4 1 Division of Oncology, Children’s Research Center, University Children’s Hospital Zürich, Zürich, 5 Switzerland 6 2 Division of Oncology, University Children’s Hospital Zürich, Zürich, Switzerland 7 8 *e-mail: [email protected] 9 10 Abstract 11 Proliferation and motility are mutually exclusive biological processes associated with cancer that depend 12 on precise control of upstream signaling pathways with overlapping functionalities. We find that STRN3 13 and STRN4 scaffold subunits of the STRIPAK complex interact with MAP4K4 for pathway regulation in 14 medulloblastoma. Disruption of the MAP4K4-STRIPAK complex impairs growth factor-induced 15 migration and tissue invasion and stalls YAP/TAZ target gene expression and oncogenic growth. The 16 migration promoting functions of the MAP4K4-STRIPAK complex involve the activation of novel PKCs 17 and the phosphorylation of the membrane targeting S157 residue of VASP through MAP4K4. The anti- 18 proliferative effect of complex disruption is associated with reduced YAP/TAZ target gene expression 19 and results in repressed tumor growth in the brain tissue. This dichotomous functionality of the STRIPAK 20 complex in migration and proliferation control acts through MAP4K4 regulation in tumor cells and 21 provides relevant mechanistic insights into novel tumorigenic functions of the STRIPAK complex in 22 medulloblastoma. -
VU Research Portal
VU Research Portal Genetic architecture and behavioral analysis of attention and impulsivity Loos, M. 2012 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Loos, M. (2012). Genetic architecture and behavioral analysis of attention and impulsivity. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 28. Sep. 2021 Genetic architecture and behavioral analysis of attention and impulsivity Maarten Loos 1 About the thesis The work described in this thesis was performed at the Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands. This work was in part funded by the Dutch Neuro-Bsik Mouse Phenomics consortium. The Neuro-Bsik Mouse Phenomics consortium was supported by grant BSIK 03053 from SenterNovem (The Netherlands). -
Analysis of Protein Complexes Through Model-Based Biclustering of Label-Free Quantitative AP-MS Data
Molecular Systems Biology 6; Article number 385; doi:10.1038/msb.2010.41 Citation: Molecular Systems Biology 6:385 & 2010 EMBO and Macmillan Publishers Limited All rights reserved 1744-4292/10 www.molecularsystemsbiology.com REPORT Analysis of protein complexes through model-based biclustering of label-free quantitative AP-MS data Hyungwon Choi1, Sinae Kim2, Anne-Claude Gingras3,4 and Alexey I Nesvizhskii1,5,* 1 Department of Pathology, University of Michigan, Ann Arbor, MI, USA, 2 Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA, 3 Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, Ontario, Canada, 4 Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada and 5 Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA * Corresponding author. Department of Pathology, University of Michigan, 1301 Catherine, 4237 MS1, Ann Arbor, MI 48109, USA. Tel.: þ 1 734 764 3516; Fax: þ 1 734 936 7361; E-mail: [email protected] Received 28.8.09; accepted 7.5.10 Affinity purification followed by mass spectrometry (AP-MS) has become a common approach for identifying protein–protein interactions (PPIs) and complexes. However, data analysis and visualization often rely on generic approaches that do not take advantage of the quantitative nature of AP-MS. We present a novel computational method, nested clustering, for biclustering of label-free quantitative AP-MS data. Our approach forms bait clusters based on the similarity of quantitative interaction profiles and identifies submatrices of prey proteins showing consistent quantitative association within bait clusters. In doing so, nested clustering effectively addresses the problem of overrepresentation of interactions involving baits proteins as compared with proteins only identified as preys. -
Identification of Ovarian Cancer Gene Expression Patterns Associated
ORIG I NAL AR TI CLE JOURNALSECTION IdentifiCATION OF Ovarian Cancer Gene Expression PATTERNS Associated WITH Disease Progression AND Mortality Md. Ali Hossain1,2 | Sheikh Muhammad Saiful Islam3 | Julian Quinn4 | Fazlul Huq5 | Mohammad Ali Moni4,5 1Dept OF CSE, ManarAT International UnivERSITY, Dhaka-1212, Bangladesh Ovarian CANCER (OC) IS A COMMON CAUSE OF DEATH FROM can- 2Dept OF CSE, Jahangirnagar UnivERSITY, CER AMONG WOMEN worldwide, SO THERE IS A PRESSING NEED SaVAR, Dhaka, Bangladesh TO IDENTIFY FACTORS INflUENCING MORTALITY. Much OC PATIENT 3Dept. OF Pharmacy, ManarAT International UnivERSITY, Dhaka-1212, Bangladesh CLINICAL DATA IS NOW PUBLICALLY ACCESSIBLE (including PATIENT 4Bone BIOLOGY divisions, Garvan Institute OF age, CANCER SITE STAGE AND SUBTYPE), AS ARE LARGE DATASETS OF Medical Research, SyDNEY, NSW 2010, OC GENE TRANSCRIPTION PROfiles. These HAVE ENABLED STUDIES AustrALIA CORRELATING OC PATIENT SURVIVAL WITH CLINICAL VARIABLES AND 5The UnivERSITY OF SyDNEY, SyDNEY Medical School, School OF Medical Science, WITH GENE EXPRESSION BUT IT IS NOT WELL UNDERSTOOD HOW THESE Discipline OF Biomedical Sciences, NSW TWO ASPECTS INTERACT TO INflUENCE MORTALITY. TO STUDY THIS 1825, AustrALIA WE INTEGRATED CLINICAL AND TISSUE TRANSCRIPTOME DATA FROM Correspondence THE SAME PATIENTS AVAILABLE FROM THE Broad Institute Cancer Dept OF CSE, Jahangirnagar UnivERSITY, Dhaka, Bangladesh Genome Atlas (TCGA) portal. WE INVESTIGATED OC mRNA The UnivERSITY OF SyDNEY, SyDNEY Medical EXPRESSION LEVELS (relativE TO NORMAL PATIENT TISSUE) OF 26 School, School OF Medical Science, Discipline OF Biomedical Sciences, NSW GENES ALREADY STRONGLY IMPLICATED IN OC, ASSESSED HOW THEIR 1825, AustrALIA EXPRESSION IN OC TISSUE PREDICTS PATIENT SURVIVAL THEN em- Email: al i :hossai n@manarat :ac:bd , mohammad :moni @sydney :eduau PLOYED CoX Proportional Hazard REGRESSION MODELS TO anal- YSE BOTH CLINICAL FACTORS AND TRANSCRIPTOMIC INFORMATION TO FUNDING INFORMATION DETERMINE RELATIVE RISK OF DEATH ASSOCIATED WITH EACH FACTOR. -
Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
136 Current Genomics, 2010, 11, 136-145 Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding Silvia Sbacchi1, Francesco Acquadro2, Ignazio Calò1, Francesco Calì3 and Valentino Romano*,1,3 1Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche, Università degli Studi di Palermo, Palermo; 2Molecular Cytogenetics Group, Centro Nacional de Investigaciones Oncologicas (C.N.I.O.), and Centro de Investiga- ciones de Enfermidades Raras (CIBERER), Madrid, Spain; 3Associazione Oasi Maria SS. (I.R.C.C.S.), Troina (EN), Italy Abstract: We have used Gene Ontology (GO) and pathway analyses to uncover the common functions associated to the genes overlapping Copy Number Variants (CNVs) in autistic patients. Our source of data were four published studies [1- 4]. We first applied a two-step enrichment strategy for autism-specific genes. We fished out from the four mentioned stud- ies a list of 2928 genes overall overlapping 328 CNVs in patients and we first selected a sub-group of 2044 genes after excluding those ones that are also involved in CNVs reported in the Database of Genomic Variants (enrichment step 1). We then selected from the step 1-enriched list a sub-group of 514 genes each of which was found to be deleted or dupli- cated in at least two patients (enrichment step 2). The number of statistically significant processes and pathways identified by the Database for Annotation, Visualization and Integrated Discovery and Ingenuity Pathways Analysis softwares with the step 2-enriched list was significantly higher compared to the step 1-enriched list. In addition, statistically significant GO terms, biofunctions and pathways related to nervous system development and function were exclusively identified by the step 2-enriched list of genes. -
STRIPAK Complexes in Cell Signaling and Cancer
Oncogene (2016), 1–9 © 2016 Macmillan Publishers Limited All rights reserved 0950-9232/16 www.nature.com/onc REVIEW STRIPAK complexes in cell signaling and cancer Z Shi1,2, S Jiao1 and Z Zhou1,3 Striatin-interacting phosphatase and kinase (STRIPAK) complexes are striatin-centered multicomponent supramolecular structures containing both kinases and phosphatases. STRIPAK complexes are evolutionarily conserved and have critical roles in protein (de) phosphorylation. Recent studies indicate that STRIPAK complexes are emerging mediators and regulators of multiple vital signaling pathways including Hippo, MAPK (mitogen-activated protein kinase), nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are extensively involved in a variety of fundamental biological processes ranging from cell growth, differentiation, proliferation and apoptosis to metabolism, immune regulation and tumorigenesis. Growing evidence correlates dysregulation of STRIPAK complexes with human diseases including cancer. In this review, we summarize the current understanding of the assembly and functions of STRIPAK complexes, with a special focus on cell signaling and cancer. Oncogene advance online publication, 15 February 2016; doi:10.1038/onc.2016.9 INTRODUCTION in the central nervous system and STRN4 is mostly abundant in Recent proteomic studies identified a group of novel multi- the brain and lung, whereas STRN3 is ubiquitously expressed in 5–9 component complexes named striatin (STRN)-interacting phos- almost all tissues. STRNs share a -
Isolation and Characterization of Stretchin-Myosin Light Chain Kinase Mutants in Drosophila Melanogaster
ISOLATION AND CHARACTERIZATION OF STRETCHIN-MYOSIN LIGHT CHAIN KINASE MUTANTS IN DROSOPHILA MELANOGASTER DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree of Philosophy in the Graduate School of The Ohio State University By Deyra Marie Rodriguez, B.S. ***** The Ohio State University 2004 Dissertation Committee: Approved by Professor Amanda Simcox, Adviser Professor Arthur Burghes Adviser Professor Mark Seeger Department of Molecular Genetics Professor Harald Vaessin ABSTRACT Muscle function depends upon the molecular interaction of myosin and actin. This interaction and the function of each molecule are tightly regulated and have been extensively studied. In Drosophila, the indirect flight musculature (IFM) is a powerful model to study muscle structure and function as these muscles are dispensable for life under laboratory conditions. Furthermore, disruption of these muscles leads to a flightless behavior. Flies with mutations in the muscle regulatory light chain (MLC2) that cannot be phosphorylated at the conserved Myosin light chain kinase (Mlck) target sites are flightless, but the IFM is normal. Flight impairment is due to an altered stretch activation response, thus phosphorylation of MLC2 at the Mlck target sites is important for flight. In Drosophila, the Stretchin-Mlck (Strn-Mlck) gene encodes several Mlck-like isoforms with kinase activity as well as other isoforms lacking this domain. Analysis of the gene in this work has shown that it is expressed in both muscle and nonmuscle cell types and that some isoforms show tissue specific expression patterns. In order to understand what role Strn-Mlck plays in MLC2 regulation, mutants were isolated. Three new mutants were identified and the previously described curved mutant was shown to be an allele. -
Striatin-3G Inhibits Estrogen Receptor Activity by Recruiting a Protein Phosphatase
199 Striatin-3g inhibits estrogen receptor activity by recruiting a protein phosphatase Bailin Tan, Xinghua Long1, Harikrishna Nakshatri2, Kenneth P Nephew1 and Robert M Bigsby Department of Obstetrics and Gynecology University School of Medicine, 975 West Walnut Street (IB360), Indianapolis, Indiana 46202, USA 1Department of Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indianapolis, Indiana 47405, USA 2Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA (Correspondence should be addressed to R M Bigsby; Email: [email protected]) Abstract A splicing variant of rat striatin-3 (rSTRN3g) was found to associate with estrogen receptor-a (ERa) in a ligand-dependent manner. In two-hybrid and pull-down analyses, estradiol induced an interaction between rSTRN3g and ERa. STRN3g protein was found in nuclear extracts from rat uterus and human cell lines. Overexpression of rSTRN3g induced a decrease in ERa transcriptional activity but had no effect on ERb activity. Immunoprecipitation analyses showed that rSTRN3g interacts with both the ERa and the catalytic subunit of protein phosphatase 2A (PP2A(C)). The transrepressor action of rSTRN3g was overcome by okadaic acid, an inhibitor of PP2A(C), and by cotransfection of PP2A(C) siRNA. rSTRN3g caused dephosphorylation of ERa at serine 118 and this was abrogated by okadaic acid. ERa lacking phosphorylation sites at either serine 118 or 167 was insensitive to the corepressor action of rSTRN3g. These observations suggest that an rSTRN3g-PP2A(C) complex is recruited to agonist-activated ERa, thereby leading to its dephosphorylation and inhibiting transcription. Journal of Molecular Endocrinology (2008) 40, 199–210 Introduction occurs early after stimulation and is maintained through at least 24 h. -
The Ancestor of Extant Japanese Fancy Mice Contributed to the Mosaic Genomes of Classical Inbred Strains
Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Revised Resources The ancestor of extant Japanese fancy mice contributed to the mosaic genomes of classical inbred strains 1, 8 2, 3 3 4 Toyoyuki Takada, Toshinobu Ebata, Hideki Noguchi, Thomas M. Keane, David 4 2 2, 3 5, 8 3 J. Adams, Takanori Narita, Tadasu Shin-I, Hironori Fujisawa, Atsushi Toyoda, 6 6 7 6 Kuniya Abe, Yuichi Obata, Yoshiyuki Sakaki, Kazuo Moriwaki, Asao Fujiyama, 3 2 1, 8* Yuji Kohara and Toshihiko Shiroishi 1 Mammalian Genetics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan 2 Genome Biology Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan 3 Comparative Genomics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan 4 The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK 5 The Institute of Statistical Mathematics, 10-3 Midori-cho, Tachikawa, Tokyo 190-8562, Japan 6 BioResource Center, RIKEN Tsukuba Institute, Tsukuba, Ibaraki 305-0074, Japan 1 Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press 7 Genome Science Center, RIKEN Yokohama Institute, Yokohama, Kanagawa 230-0045, Japan; present address, Toyohashi University of Technology, Hibarigaoka, Tempaku, Toyohashi, Aichi 441-8580, Japan 8 Transdisciplinary Research Integration Center, Research Organization of Information and Systems, Minato-ku, Tokyo 105-0001, Japan *Corresponding author. E-mail: [email protected] Mammalian Genetics Laboratory, National Institute of Genetics, 1111 Yata, Mishima, Shizuoka 411-8540, Japan TEL: +81-55-981-6818, FAX: +81-55-981-6817 Keywords: mouse genome, MSM/Ms, JF1/Ms, inter-subspecific genome difference Running title: Mus musculus molossinus genome 2 Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Commonly used classical inbred mouse strains have mosaic genomes with sequences from different subspecific origins. -
Recovering Protein-Protein and Domain-Domain Interactions from Aggregation of IP-MS Proteomics of Coregulator Complexes
Recovering Protein-Protein and Domain-Domain Interactions from Aggregation of IP-MS Proteomics of Coregulator Complexes Amin R. Mazloom1, Ruth Dannenfelser1, Neil R. Clark1, Arsen V. Grigoryan2, Kathryn M. Linder2, Timothy J. Cardozo2, Julia C. Bond1, Aislyn D. W. Boran1, Ravi Iyengar1, Anna Malovannaya3, Rainer B. Lanz3, Avi Ma’ayan1* 1 Department of Pharmacology and Systems Therapeutics, Systems Biology Center New York (SBCNY), Mount Sinai School of Medicine, New York, New York, United States of America, 2 Department of Pharmacology, New York University School of Medicine, New York, New York, United States of America, 3 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America Abstract Coregulator proteins (CoRegs) are part of multi-protein complexes that transiently assemble with transcription factors and chromatin modifiers to regulate gene expression. In this study we analyzed data from 3,290 immuno-precipitations (IP) followed by mass spectrometry (MS) applied to human cell lines aimed at identifying CoRegs complexes. Using the semi- quantitative spectral counts, we scored binary protein-protein and domain-domain associations with several equations. Unlike previous applications, our methods scored prey-prey protein-protein interactions regardless of the baits used. We also predicted domain-domain interactions underlying predicted protein-protein interactions. The quality of predicted protein-protein and domain-domain interactions was evaluated using known binary interactions from the literature, whereas one protein-protein interaction, between STRN and CTTNBP2NL, was validated experimentally; and one domain- domain interaction, between the HEAT domain of PPP2R1A and the Pkinase domain of STK25, was validated using molecular docking simulations.